ADVI Health’s senior advisor, Norris Turner, PharmD, PhD, attended the AMCP Foundation Research Symposium, which took place in Dallas, TX, on December 3-4.
While there, Norris moderated a panel titled “Addressing Disparities in the Evidence-Based Use of Biomarker-Driven Precision Oncology” on Wednesday, December 4, from 8:30 am to 9:15 am. The panel expanded on how access to and receipt of appropriate biomarker testing must be an attainable goal to ensure equal access to quality care. Joining him, esteemed panelists Ira Klein, MD, MBA, and Lalan Wilfong, MD, delivered a powerful conversation shaping the future of precision oncology.
Get in touch and learn more.
